The final decision now rests with the FDA itself.
It would be the first treatment in the U.S. that fixes an inherited genetic trait.
We need to make this happen.
Their novel gene therapy method makes retinal cells sensitive to light.
It could end the need for children to undergo painful surgeries.
Over 350,000 people subscribe to our newsletter.
Sign in to join the conversation.